Product Information
METHYLPHENIDATE 10 MG/5 ML SOL is a generic product labeled by Eywa Pharma Inc, priced at $0.1199 per ML under NDC 71930002552. Its NADAC has been published 383 times since Jun 5, 2019.
FDA first approved this application on Oct 3, 2018. Its Orange Book therapeutic-equivalence code is AA.
Strength
10 mg/5mL
Manufacturer
Eywa Pharma IncNDC
71930002552
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210139FDA Approved
10/3/2018
TE Code
AA
On Market Since
3/29/2019
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE 10 MG/5 ML SOL has been published 383 times since Jun 5, 2019, and over the history we have for it it has declined 26.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1199 per ML |
|---|---|
| All-time high | $0.2069 (Apr 15, 2020) |
| All-time low | $0.0932 (Nov 20, 2024) |
| 52-week high | $0.1241 |
| 52-week low | $0.1106 |
| Median price | $0.1407 |
| Average price | $0.1421 |
| Largest weekly change | +49.8% (Jun 21, 2023) |
| Weeks tracked | 383 |
| Tracking since | Jun 5, 2019 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Eywa Pharma Inc manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Methylphenidate Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE 10 MG/5 ML SOL?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 10 MG/5 ML SOL, manufactured by Eywa Pharma Inc, is $0.1199 per ML (NDC 71930002552), effective Sep 30, 2026.
How has the price of METHYLPHENIDATE 10 MG/5 ML SOL changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE 10 MG/5 ML SOL has declined 26.4%. It has been tracked across 383 weekly CMS publications since Jun 5, 2019.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 10 MG/5 ML SOL?
Since Jun 5, 2019, the NADAC for METHYLPHENIDATE 10 MG/5 ML SOL has ranged from a low of $0.0932 (Nov 20, 2024) to a high of $0.2069 (Apr 15, 2020), with a median of $0.1407 per ML.
Are there cheaper alternatives to METHYLPHENIDATE 10 MG/5 ML SOL?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPHENIDATE 10 MG/5 ML SOL, is $0.1133 per ML — about 6% below METHYLPHENIDATE 10 MG/5 ML SOL.
Who manufactures METHYLPHENIDATE 10 MG/5 ML SOL?
METHYLPHENIDATE 10 MG/5 ML SOL (NDC 71930002552) is labeled by Eywa Pharma Inc, and CMS classifies it as a generic product.